Alibaba Health 0241

Alibaba Health 0241

Postby winston » Thu Apr 16, 2015 4:13 am

not vested

Health in Alibaba sights

Mainland e-commerce firm Alibaba Group Holding is injecting its online pharmacy operations into a Hong Kong-listed affiliate in a HK$19.45 billion deal to consolidate its health-care enterprise and ride a boom in online health-related business.

Shares in the affiliate, Alibaba Health Information Technology (0241), nearly doubled early yesterday after the announcement on a resumption of trading after being suspended since March 20.

Alibaba Health will buy 100 percent of the online pharmacy operations from a wholly owned subsidiary of Alibaba Group and another investor. It will issue shares and bonds to fund the purchase, with the shares priced at HK$5.28 each.

"We expect that this integration will enable Alibaba Group to build a health-care ecosystem that can utilize e-commerce, big data and other technologies to improve the health-care supply chain," Alibaba Group chief operating officer Daniel Zhang said.

Online pharmacies are currently limited to selling over-the-counter medicines and health-care products such as cough remedies and vitamin tablets, but China is gearing up to open the prescription drug market to online pharmacy operators like Alibaba Health, JD.com and Wal-Mart Stores.

The deal, which is subject to approval by independent shareholders of Alibaba Health, is expected to be completed in the third quarter this year, raising Alibaba Group's effective equity ownership of Alibaba Health to about 53 percent from 38 percent and making it a consolidated subsidiary, it said.

Rivals such as Tencent Holdings (0700), JD.com and Baidu have all made moves to get into China's online health-care market, seen as a potential cure for a fragmented and opaque market controlled by state-run distributors and hospitals.

Source: REUTERS
It's all about "how much you made when you were right" & "how little you lost when you were wrong"
User avatar
winston
Billionaire Boss
 
Posts: 118528
Joined: Wed May 07, 2008 9:28 am

Re: Alibaba Health 0241

Postby behappyalways » Thu Apr 16, 2015 12:24 pm

阿里健康獲注194億藥網
牌照最矜貴 去年價值300萬
http://hk.apple.nextmedia.com/financees ... 6/19114081
血要热 头脑要冷 骨头要硬
behappyalways
Millionaire Boss
 
Posts: 39914
Joined: Wed Oct 15, 2008 4:43 pm

Re: Alibaba Health 0241

Postby winston » Fri Dec 18, 2015 9:51 am

not vested

Nov 24, 2015

<Result Ann>ALI HEALTH (00241.HK) Interim Loss Widens to $125M

ALI HEALTH (00241.HK) announced results for the first half of the financial year ended 30 September 2015.

Revenue gained 14.6% yearly to $21.37 million.

Loss expanded to $125 million from that of $33.76 million in the year-ago period.

LPS was 1.54 cents. No interim dividend was declared.

Source: AAStocks Financial News
It's all about "how much you made when you were right" & "how little you lost when you were wrong"
User avatar
winston
Billionaire Boss
 
Posts: 118528
Joined: Wed May 07, 2008 9:28 am

Re: Alibaba Health 0241

Postby winston » Wed Feb 12, 2020 1:45 pm

not vested

ALI HEALTH(241)

Analysis:

On February 6, 2020, Ali Health entered into the Share Purchase Agreement with Ali JK Nutritional Products Holding Limited.

The target business comprises
(i) all Merchant relationships with the merchants for the sale of the Pharmaceutical Products, the Medical Devices, the Healthcare Products, the Medical Purpose Food Products; and the Medical and Healthcare Services on the Tmall Platforms; and
(ii) the employment relationships with relevant marketing and operations personnel managing the relationships with the merchants.

The company believes that its acquisition will enable it to:
(a) further develop into Alibaba Group`s only healthcare flagship platform;
( b) bring in an even broader set of merchants! into the online healthcare community to enrich the ecosystem, and to organically complement and supplement the company`s four main businesses: pharmaceutical e-commerce, Internet healthcare, intelligent medicine and product tracking platform services; and
(c) obtain more stable and sustainable revenue growth.

Strategy:
Buy-in Price: $13.00, Target Price: $14.60, Cut Loss Price: $12.50

Source: Phillips
It's all about "how much you made when you were right" & "how little you lost when you were wrong"
User avatar
winston
Billionaire Boss
 
Posts: 118528
Joined: Wed May 07, 2008 9:28 am

Re: Alibaba Health 0241

Postby winston » Thu Jun 18, 2020 11:18 am

not vested

ALI HEALTH(241)

Analysis:

Alibaba Health (241) takes users as the core, fully committed to promote medical e-commerce and new retail business in all channels.

It aims to provide a comprehensive and on-offline integrated solution for the health industry.

The company`s revenue for the fiscal year ended March this year was RMB 9.6 billion, higher than the market expectation by 6%.

The corresponding net loss for the year has decreased to RMB 6.6million, which is also above market expectation of RMB 83.3 million.

During the Covid-19 outbreak, the Chinese Government has issued a series of policies to support “internet + medical” services in China. (ie open up the sales of online prescription drugs and the inclusion of online initial medical consultations and online medicine purchases into the scope for medical insurance reimbursement.

Alibaba, being the market leader in the industry, will be the major beneficiary of these new policies.

Further, we believe the company will further capture the future opportunities of its industry and further strengthen its market leader position by utilizing the support and synergies created with the Alibaba Group.

Strategy:
Buy-in Price: $20.30, Target Price: $16.40, Cut Loss Price: $22.30

Source: Phillips
It's all about "how much you made when you were right" & "how little you lost when you were wrong"
User avatar
winston
Billionaire Boss
 
Posts: 118528
Joined: Wed May 07, 2008 9:28 am

Re: Alibaba Health 0241

Postby winston » Fri Jul 24, 2020 12:14 pm

not vested

ALI HEALTH(241)

Analysis:

Alibaba Health (00241.HK) takes users as the core, fully committed to promote medical e-commerce and new retail business in all channels.

It aims to provide a comprehensive and on-offline integrated solution for the health industry.

The company's revenue for the fiscal year ended March this year was RMB 9.6 billion, higher than the market expectation by 6%.

The corresponding net loss for the year has decreased to RMB 6.6million, which is also above market expectation of RMB 83.3 million.

The Chinese Government has recently announced that on the premise of ensuring medical safety and quality, they will further relax the scope of Intern et diagnosis and treatment.

Alibaba Health , being the market leader in the industry, will be the major beneficiary of this announcement.

Further, we believe the company will further capture the future opportunities of the industry and further strengthen its market leader position by utilizing the support and synergies created with the Alibaba Group.

Strategy:
Buy-in Price: $22.30 Target Price: $24.50, Cut Loss Price: $21.20

Source: Phillips
It's all about "how much you made when you were right" & "how little you lost when you were wrong"
User avatar
winston
Billionaire Boss
 
Posts: 118528
Joined: Wed May 07, 2008 9:28 am

Re: Alibaba Health 0241

Postby winston » Wed Aug 05, 2020 2:31 pm

not vested

Alibaba Health raises $1.3 billion in Hong Kong's biggest secondary share sale in five years

The Chinese company, an arm of internet retail giant Alibaba Group, said on Wednesday it would issue 499 million new shares priced at HK$20.05 ($2.59) apiece, an 8% discount to the stock's HK$21.80 closing price in Hong Kong on Tuesday.


Source: Thomson Reuters

https://whtc.com/news/articles/2020/aug ... n=business
It's all about "how much you made when you were right" & "how little you lost when you were wrong"
User avatar
winston
Billionaire Boss
 
Posts: 118528
Joined: Wed May 07, 2008 9:28 am

Re: Alibaba Health 0241

Postby winston » Wed Jan 20, 2021 10:58 am

not vested

ALI HEALTH(241)

Analysis:

Ali Health (241) continues to actively expand its cooperation with recognized upstream brands, and further strengthen its business partnerships with pharmaceutical, nutritional and healthcare product manufacturers and major domestic pharmaceutical distributors, providing consumers with a wide range of health products including prescription drugs, over-the-counter (OTC) drugs, health supplements, medical devices and contact lenses.

Meanwhile, the Group`s service capabilities in warehousing, logistics, customer service, quality control, etc. were further enhanced.

In terms of warehousing and logistics, in order to expand the geographic coverage of goods and improve the efficiency of delivery, the Group had built a distribution network with nine warehouses located in seven different locations thus making next-day delivery available in 60 key cities.

Additionally, the Group has been equipped with cold chain storage and distribution capacity in direct-to-patient (DTP) service, and its application in new and cancer drugs had been commenced. (I do not hold the above stock)

Strategy:
Buy-in Price: $23.00, Target Price: $26.00, Cut Loss Price: $21.50

Source: Phillips
It's all about "how much you made when you were right" & "how little you lost when you were wrong"
User avatar
winston
Billionaire Boss
 
Posts: 118528
Joined: Wed May 07, 2008 9:28 am


Return to A to B

Who is online

Users browsing this forum: No registered users and 7 guests

cron